BetterLife PharmaBETRF -7.66%28 Dividend Yield % is 0.00% as of Jun. 29, 2026. GuruFocus rates BETRF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 153 Biotechnology companies, BetterLife Pharma ranks worse than 653594.12% on this metric.
As of today (2026-06-29), the Trailing Annual Dividend Yield of BetterLife Pharma is 0.00%.
The historical rank and industry rank for BetterLife Pharma's Dividend Yield % or its related term are showing as below:
BETRF's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.51 * Ranked among companies with meaningful Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
BetterLife Pharma Dividend Yield % Historical Data
* Premium members only.
The historical data trend for BetterLife Pharma's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BETRF vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, BetterLife Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BetterLife Pharma Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where BetterLife Pharma's Dividend Yield % falls into.
BetterLife Pharma (BETRF) has a Dividend Yield % of 0.00% as of Jun. 29, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on BetterLife Pharma and its competitors. According to the industry distribution chart, BetterLife Pharma ranks #999999 out of 153 companies in the Biotechnology industry.
Is BetterLife Pharma's Dividend Yield % too high?
BetterLife Pharma's current Dividend Yield % is 0.00%. Based on the distribution chart, BetterLife Pharma ranks #999999 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BetterLife Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BetterLife Pharma ranks #999999 out of 153 companies for Dividend Yield %. This places BetterLife Pharma in the lower half of its industry. The industry median Dividend Yield % is 1.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.51, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on BetterLife Pharma and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BetterLife Pharma's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. BetterLife Pharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Dividend Yield % is 0.00% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
28GF Score
Get the complete analysis for BETRF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BETRF has been successfully added to your 
